The study also included an 18-week open-label phase, during which patients with Schizophrenia were treated with Lumateperone 42 mg per day. The biopharmaceutical company found that the time to relapse ...

Data presented at Psych Congress 2024 showed improvements in social functioning and quality of life over an eight-week ...

Bristol Myers Squibb's (BMY) new schizophrenia drug, Cobenfy, improves symptoms with a well-tolerated safety profile in two ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday.

Squibb “announced new topline results from the Phase 3 EMERGENT-4 and EMERGENT-5 open-label trials evaluating the ...

Outside the accident and emergency department in Coventry is a man in a wheelchair. He is in a pitiful state. His legs and feet are swollen, causing him intense pain, but more than anything else ...

Emil Riis ensured Preston's unbeaten home record under Paul Heckingbottom continued as the Lilywhites beat Coventry 1-0 in the Sky Bet Championship. The 26-year-old headed home a 72nd-minute ...

They did arrive back at different times, so Coventry have had to manage that dynamic. Jake Bidwell will be missing, but the defender’s injury is not as bad as the Sky Blues initially feared.

Funds raised during the event will help pay for travel expenses for Kissinger who will soon begin additional treatment at Johns Hopkins Hospital in Maryland. The rough cost will be about $1,000 a ...

Preliminary results demonstrated a dose-dependent effect of ANAVEX ® 3-71 on two key EEG biomarkers in patients with schizophrenia. Treatment with ANAVEX ® 3-71 compared to placebo resulted in ...

As schizophrenia develops, the symptoms can mimic other conditions, which causes a delay in treatment, which negatively impacts the prognosis of the illness, said Megan Ehret, PharmD, MS, BCPP ...